Literature DB >> 17526422

Intermittent preventive treatment of malaria in pregnancy: a community-based delivery system and its effect on parasitemia, anemia and low birth weight in Uganda.

Anthony K Mbonye1, Ib Bygbjerg, Pascal Magnussen.   

Abstract

OBJECTIVE: The main objective of the study was to assess the impact of a community-based delivery system of intermittent preventive treatment (IPT) for malaria in pregnancy with sulfadoxine-pyrimethamine (SP) on access, parasitemia, anemia and low birth weight as primary outcome measures.
METHODS: A study was designed to test the community-based delivery system of IPT through traditional birth attendants (TBAs), drug-shop vendors (DSVs), community reproductive health workers (CRHWs) and adolescent peer mobilizers (APMs), and to compare these with IPT at health units in an area of high malaria transmission - Mukono District, Uganda.
RESULTS: Two thousand seven hundred and eighty-five pregnant women participated in the study. The majority of the women (92.4%) at the community-based approaches received their first dose of IPT during their second trimester compared to 76.1% at health units (p<0.0001). At both health units and the community-based approaches, IPT increased mean hemoglobin by 6.7% (p<0.0001) for all parities and by 10.2% among primigravidae. IPT reduced the prevalence of severe anemia from 5.7% to 3.1% (p<0.04). The prevalence of parasitemia was reduced from 24.5% to 16.1% (p<0.001), and parasite density reduced significantly (p<0.02) after the first dose and remained stable with the second dose. Overall the proportion of low birth weight was 6.3% (8.3% at health units versus 6.0% at the community-based approaches, p<0.03) highlighting the importance of access and adherence to IPT. This intervention was acceptable to 89.6% of the women at the community-based approaches intending to use IPT in the future, while 48.1% of them had recommended it to other women.
CONCLUSIONS: The community-based approaches increased access and adherence to IPT with an effect on anemia, severe anemia, parasitemia and low birth weight. However the reduced effect of IPT on parasitemia points to drug resistance with SP and this requires further evaluation; research into the identification of other more efficacious drugs for malaria prevention in pregnancy is also required.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17526422     DOI: 10.1016/j.ijid.2006.10.008

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  19 in total

1.  Intermittent preventive treatment with sulfadoxine-pyrimethamine against malaria and anemia in pregnant women.

Authors:  Nana O Wilson; Fatou K Ceesay; Samuel A Obed; Andrew A Adjei; Richard K Gyasi; Patricia Rodney; Yassa Ndjakani; Winston A Anderson; Naomi W Lucchi; Jonathan K Stiles
Journal:  Am J Trop Med Hyg       Date:  2011-07       Impact factor: 2.345

2.  Prevalence of Plasmodium falciparum resistance markers to sulfadoxine-pyrimethamine among pregnant women receiving intermittent preventive treatment for malaria in Uganda.

Authors:  Anthony K Mbonye; Josephine Birungi; Stephanie K Yanow; Sandra Shokoples; Samuel Malamba; Michael Alifrangis; Pascal Magnussen
Journal:  Antimicrob Agents Chemother       Date:  2015-06-29       Impact factor: 5.191

3.  Effect of intermittent preventive treatment of malaria on the outcome of pregnancy among women attending antenatal clinic of a new Nigerian teaching hospital, Ado-Ekiti.

Authors:  Aduloju Olusola Peter
Journal:  Niger Med J       Date:  2013-05

4.  Burden of malaria during pregnancy at the time of IPTp/SP implementation in Gabon.

Authors:  Marielle K Bouyou-Akotet; Solange Nzenze-Afene; Edgard B Ngoungou; Eric Kendjo; Mathieu Owono-Medang; Jean-Bernard Lekana-Douki; Ghislaine Obono-Obiang; Mathieu Mounanga; Maryvonne Kombila
Journal:  Am J Trop Med Hyg       Date:  2010-02       Impact factor: 2.345

5.  Intermittent preventive treatment of malaria in pregnancy: a new delivery system and its effect on maternal health and pregnancy outcomes in Uganda.

Authors:  A K Mbonye; I C Bygbjerg; P Magnussen
Journal:  Bull World Health Organ       Date:  2008-02       Impact factor: 9.408

Review 6.  Malaria in pregnancy: the difficulties in measuring birthweight.

Authors:  M J Rijken; J A Rijken; A T Papageorghiou; S H Kennedy; G H A Visser; F Nosten; R McGready
Journal:  BJOG       Date:  2011-02-18       Impact factor: 6.531

7.  Individual, facility and policy level influences on national coverage estimates for intermittent preventive treatment of malaria in pregnancy in Tanzania.

Authors:  Tanya Marchant; Rose Nathan; Caroline Jones; Hadji Mponda; Jane Bruce; Yovitha Sedekia; Joanna Schellenberg; Hassan Mshinda; Kara Hanson
Journal:  Malar J       Date:  2008-12-18       Impact factor: 2.979

8.  Knowledge and utilization of intermittent preventive treatment for malaria among pregnant women attending antenatal clinics in primary health care centers in rural southwest, Nigeria: a cross-sectional study.

Authors:  Stella O Akinleye; Catherine O Falade; Ikeoluwapo O Ajayi
Journal:  BMC Pregnancy Childbirth       Date:  2009-07-09       Impact factor: 3.007

9.  Prescription patterns and drug use among pregnant women with febrile Illnesses in Uganda: a survey in out-patient clinics.

Authors:  Anthony K Mbonye; Josephine Birungi; Stephanie Yanow; Pascal Magnussen
Journal:  BMC Infect Dis       Date:  2013-05-23       Impact factor: 3.090

10.  Translating health research evidence into policy and practice in Uganda.

Authors:  Anthony K Mbonye; Pascal Magnussen
Journal:  Malar J       Date:  2013-08-05       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.